Business
CARDEO: Improved results, portfolio write-down, and new capital mark Cardeon's challenging 2024
CARDEO: Improved results, portfolio write-down, and new capital mark Cardeon's challenging 2024
About this update from Cardeon Ab
Cardeon's 2024 saw improved operating results, a major portfolio write-down, and new capital raised, while the listed portfolio underperformed the market. Management remains optimistic about long-term value creation in life science and medtech. Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.